COVID-19 epidemiology

Aneeka Ratnayake; April McDougal; Patricia Kissinger; Theresa Sokol; Crystal Zheng

doi:10.1016/B978-0-323-91812-1.00017-2

COVID-19 epidemiology

Aneeka Ratnayake
, April McDougal
, Patricia Kissinger
, Theresa Sokol
, Crystal Zheng

Internal Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

COVID-19, the disease caused by SARS-CoV-2, was first introduced to human populations in December, 2019. There was no pre-existing population immunity and thus the disease spread rapidly throughout the globe. Since its emergence, greater population level immunity has been acquired, notably through the advent of vaccines; however, newer COVID-19 variants have also resulted in increased transmissibility.

Original language	English (US)
Title of host publication	COVID-19 Viral Sepsis
Subtitle of host publication	Impact on Disparities, Disability, and Health Outcomes
Publisher	Elsevier
Pages	53-85
Number of pages	33
ISBN (Electronic)	9780323918121
ISBN (Print)	9780323972383
DOIs	https://doi.org/10.1016/B978-0-323-91812-1.00017-2
State	Published - Jan 1 2023

Keywords

COVID-19
EUA
epidemiology
pandemic
therapeutics
vaccine

ASJC Scopus subject areas

General Medicine
General Immunology and Microbiology

Access to Document

10.1016/B978-0-323-91812-1.00017-2

Cite this

@inbook{2205c1ff4a52455cb55cb503596550f3,

title = "COVID-19 epidemiology",

abstract = "COVID-19, the disease caused by SARS-CoV-2, was first introduced to human populations in December, 2019. There was no pre-existing population immunity and thus the disease spread rapidly throughout the globe. Since its emergence, greater population level immunity has been acquired, notably through the advent of vaccines; however, newer COVID-19 variants have also resulted in increased transmissibility.",

keywords = "COVID-19, EUA, epidemiology, pandemic, therapeutics, vaccine",

author = "Aneeka Ratnayake and April McDougal and Patricia Kissinger and Theresa Sokol and Crystal Zheng",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-91812-1.00017-2",

language = "English (US)",

isbn = "9780323972383",

pages = "53--85",

booktitle = "COVID-19 Viral Sepsis",

publisher = "Elsevier",

}

TY - CHAP

T1 - COVID-19 epidemiology

AU - Ratnayake, Aneeka

AU - McDougal, April

AU - Kissinger, Patricia

AU - Sokol, Theresa

AU - Zheng, Crystal

PY - 2023/1/1

Y1 - 2023/1/1

N2 - COVID-19, the disease caused by SARS-CoV-2, was first introduced to human populations in December, 2019. There was no pre-existing population immunity and thus the disease spread rapidly throughout the globe. Since its emergence, greater population level immunity has been acquired, notably through the advent of vaccines; however, newer COVID-19 variants have also resulted in increased transmissibility.

AB - COVID-19, the disease caused by SARS-CoV-2, was first introduced to human populations in December, 2019. There was no pre-existing population immunity and thus the disease spread rapidly throughout the globe. Since its emergence, greater population level immunity has been acquired, notably through the advent of vaccines; however, newer COVID-19 variants have also resulted in increased transmissibility.

KW - COVID-19

KW - EUA

KW - epidemiology

KW - pandemic

KW - therapeutics

KW - vaccine

UR - https://www.scopus.com/pages/publications/85176365821

UR - https://www.scopus.com/pages/publications/85176365821#tab=citedBy

U2 - 10.1016/B978-0-323-91812-1.00017-2

DO - 10.1016/B978-0-323-91812-1.00017-2

M3 - Chapter

AN - SCOPUS:85176365821

SN - 9780323972383

SP - 53

EP - 85

BT - COVID-19 Viral Sepsis

PB - Elsevier

ER -

COVID-19 epidemiology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this